ABSTRACT
O linfedema é a complicação mais frequente no pós-operatório de câncer de mama, podendo afetar diretamente as atividades diárias. O objetivo desse estudo foi verificar o uso do taping como forma alternativa/auxiliar de tratamento na redução do linfedema. Foi realizada uma revisão da literatura de artigos científicos indexados nas bases de dados PubMed, LILACS, MEDLINE, PEDro e Google Acadêmico, onde foram selecionados nove artigos científicos. Verificou-se que o uso do taping é uma técnica complementar na redução do linfedema, podendo ser uma forma alternativa de tratamento para a redução deste, apesar de não ser capaz de substituir a terapia compressiva multicamadas
Lymphedema is the most common complication during the postoperative period after surgery for breast cancer and can have a direct impact on daily activities. The objective of this study was to review the use of taping as an alternative/complementary treatment to reduce lymphedema. A literature review was conducted of scientific articles indexed on the PubMed, LILACS, MEDLINE, and PEDro databases and Google Scholar, and nine articles were selected. It was found that taping is a complementary therapy for reducing lymphedema, which may be used as an alternative treatment method, but cannot substitute multilayer compression therapy.
Subject(s)
Humans , Female , Athletic Tape/ethics , Breast Cancer Lymphedema/rehabilitation , Breast Neoplasms/rehabilitation , Lymphatic System/pathologyABSTRACT
La hipertrofia ventricular izquierda es un predictor de riesgo de eventos cardiovasculares. Los objetivos del presente trabajo fueron establecer los valores de referencia para la masa ventricular izquierda en una población aparentemente sana de la Ciudad Autónoma de Buenos Aires, analizar su correlación con la edad y variables antropométricas y definir la mejor manera de expresar esos datos. Para el cálculo de la masa ventricular izquierda se utilizó metodología ecocardiográfica avalada internacionalmente (American Society of Echocardiography/European Association of Echocardiography) y la fórmula de Devereux ajustada. Luego de aplicar criterios de exclusión estrictos, se incluyeron 1.898 individuos, 48,89% hombres y 51,1% mujeres (edad 38 ± 11 años). El valor de masa ventricular izquierda fue para hombres de 155 ± 30 g (percentil 95 206 g), con distribución normal, y para mujeres de 112 ± 24 g (percentil 95 153 g), con distribución no normal (p < 0,001 entre géneros). Los valores son comparables a los referidos en estudios con similar metodología. Los índices de masa ventricular izquierda calculados mostraron una correlación moderada para superficie corporal y peso, y diferencias significativas entre géneros. Las distintas variables calculadas exhibieron heterogeneidad en el tipo de distribución (normal o no normal) de sus datos, por lo que consideramos que el percentil 95 es la mejor manera de expresar los valores de referencia. En conclusión, se estimaron los valores de referencia para masa ventricular izquierda en una población sana y se observó una correlación moderada con superficie corporal y peso. Proponemos la utilización del percentil 95 para expresar el valor superior de referencia para los datos obtenidos.
Left ventricular hypertrophy is a risk predictor of cardiovascular events. The objectives of this study were to establish reference values for left ventricular mass in an apparently healthy population of the Autonomous City of Buenos Aires, to analyze its correlation with age and anthropometric variables and to define the best way to express the assessed data. Left ventricular mass was estimated using internationally supported echocardiographic methods (American Society of Echocardiography/European Association of Echocardiography) and the adjusted Devereux equation. After applying strict exclusion criteria, 1898 subjects with mean age of 38 ± 11 years, 48.89% of whom were male and 51.1% were female, were included in the study. Left ventricular mass was 155 ± 30 g for men (95th percentile 206 g) with normal distribution, and 112 ± 24 g for women (95th percentile 153 g) with non-normal distribution (p < 0.001 between genders). Values were comparable to those reported in studies using a similar methodology. Left ventricular mass index showed a moderate correlation with body surface area and weight, and significant differences between genders. As calculated variables exhibited heterogeneity in data distribution (normal or non-normal), the 95th percentile was assumed as the best way of expressing reference values. In conclusion, estimated reference values of left ventricular mass in a healthy population moderately correlated with body surface area and weight. We propose the use of the 95th percentile to express the upper reference value of the assessed data.
ABSTRACT
La tromboendarterectomía pulmonar es la terapéutica de elección para pacientes con hipertensión pulmonar tromboembólica crónica. Objetivos: Reportar la experiencia en tromboendarterectomía pulmonar a 18 años de seguimiento. Material y Métodos: Se analizaron retrospectivamente 41 pacientes entre Noviembre 1992 y Agosto 2010.Criterios de inclusión: presión arterial pulmonar media >30 mmHg y resistenciavascular pulmonar (RVP) >300 dinas/sg. cm-5. La angiografía pulmonar determinó la factibilidad quirúrgica. La supervivencia se calculó utilizando el método de Kaplan-Meier y para comparar 2 grupos log-rank test.Resultados: El 44% de los pacientes estaban en clase funcional IV. Los cambios hemodinámicos posteriores a la tromboendarterectomía fueron significativos p <0.001. La PAPm 53 ± 2 a 29 ± 2 mmHg, la RVP 857 ± 65 a 245 ± 25 dinas/sg. cm-5 y el IC 2,3 ± 0,1a 3 ± 0,1. La mortalidad hospitalaria fue 15%, en CF II-III 4% y en CF IV 33% (p=0.01). La mortalidad alejada fue 11%. El 93% de los pacientes mejoró su clase funcional. La supervivencia global a 1, 2, 5, 10 años fue del 85%, 82%, 75% y 71% respectivamente.La supervivencia por clase funcional mostró diferencias significativas (p=0.02). Conclusión: En nuestra experiencia la tromboendarterectomía pulmonar mostró beneficios en esta población de alto riesgo.
Pulmonary thromboendarterectomy is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension. Objective: To report our 18-years experience in pulmonary thromboendarterectomy. Material and Methods: Forty one patients were analyzed between November/1992 andAugust/2010. Inclusion criteria: mean pulmonary artery pressure (PAPm) >30 mmHg and pulmonary vascular resistance (PVR) >300 dinas/sec.cm-5. Pulmonary angiography determined the surgical feasibility. Survival was calculated using the Kaplan-Meiermethod and to compare the 2 groups log rank test. results: Pulmonary thromboendarterectomy is the treatment of choice for patients with chronicthromboembolic pulmonary hypertension. Objective: To report our 18-years experience in pulmonary thromboendarterectomy. Material and Methods: Forty one patients were analyzed between November/1992 andAugust/2010. Inclusion criteria: mean pulmonary artery pressure (PAPm) >30 mmHg and pulmonary vascular resistance (PVR) >300 dinas/sec.cm-5. Pulmonary angiography determined the surgical feasibility. Survival was calculated using the Kaplan-Meiermethod and to compare the 2 groups log rank test. Results: Forty four percent of the patients were classified in class IV. The hemodynamic changesafter pulmonary thromboendarterectomy were significant (p < 0.001). PAPm 53 ± 2 vs. 29 ± 2 mm Hg, PVR 857 ± 65 vs. 245 ± 25 dinas/sec. cm-5 and CI 2.3 ± 0.1 vs. 3 ± 0.1. In-hospital mortality was 15%; in classes II - III was 4%, and in class IV 33% (p = 0.01). Late mortality was 12%. Ninety three percent of the patients improved their functional class. Overall survival at 1,2, 5 and 10 years was 85%, 82%, 75% and 71% respectively. Survival according to functional class showed significant differences (p = 0.02).Conclusion: In our experience pulmonary thromboendarterectomy showed benefits even in thishigh risk population.
Subject(s)
Humans , Male , Adolescent , Adult , Female , Young Adult , Middle Aged , Endarterectomy , Hypertension, Pulmonary/surgery , Chronic Disease , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/drug therapy , Survival RateABSTRACT
Chronic thromboembolic pulmonary hypertensión (CTPH) usually develops as a consequence of an unresolved pulmonary thromboembolism (PTE). Clinically it can evolucionate from different forms, being in many times similar in its presentation to the idiopathic pulmonary hypertension (IPH), motive by which is frequently misdiagnosed. The treatment of choice is the pulmonary thromboendarterectomy (PT)... An unfrequent case of a patient with a diagnosis of CTPH submitted to non-conventional treatment with pulmonary angioplasty is reported, and later on a revision of diagnosis and treatment is presented.
Subject(s)
Humans , Male , Adolescent , Angioplasty, Balloon , Endarterectomy , Pulmonary Embolism/diagnosis , Endarterectomy , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/therapyABSTRACT
El propósito del presente trabajo fue comparar las características clínicas, técnica quirúrgica y resultados hospitalarios entre hombres (H) y mujeres (M) sometidos a cirugía coronaria (CC)...Se observó que ambos sexos presentan diferencias significativas en las características clínicas basales, en la técnica quirúrgica y en los resultados hospitalarios, con peor evolución en el sexo femenino